These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21658405)

  • 1. Overdiagnosis in breast cancer: design and methods of estimation in observational studies.
    Puliti D; Miccinesi G; Paci E
    Prev Med; 2011 Sep; 53(3):131-3. PubMed ID: 21658405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
    Puliti D; Duffy SW; Miccinesi G; de Koning H; Lynge E; Zappa M; Paci E;
    J Med Screen; 2012; 19 Suppl 1():42-56. PubMed ID: 22972810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of women at high risk for breast cancer.
    Narod SA
    Prev Med; 2011 Sep; 53(3):127-30. PubMed ID: 21745498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z; Maricic M; Bassford TL; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS
    Arch Intern Med; 2005 Mar; 165(5):552-8. PubMed ID: 15767532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
    de Gelder R; Fracheboud J; Heijnsdijk EA; den Heeten G; Verbeek AL; Broeders MJ; Draisma G; de Koning HJ
    Prev Med; 2011 Sep; 53(3):134-40. PubMed ID: 21718717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population studies of the effectiveness of mammographic screening.
    Coldman A; Phillips N
    Prev Med; 2011 Sep; 53(3):115-7. PubMed ID: 21798279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
    Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
    J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening in developing countries.
    Mittra I
    Prev Med; 2011 Sep; 53(3):121-2. PubMed ID: 21712052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reality check for overdiagnosis estimates associated with breast cancer screening.
    Etzioni R; Xia J; Hubbard R; Weiss NS; Gulati R
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25362701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence base for breast cancer screening.
    Glasziou P; Houssami N
    Prev Med; 2011 Sep; 53(3):100-2. PubMed ID: 21658406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering drug use and breast cancer in older women: a prospective study.
    Cauley JA; Zmuda JM; Lui LY; Hillier TA; Ness RB; Stone KL; Cummings SR; Bauer DC
    J Womens Health (Larchmt); 2003 Oct; 12(8):749-56. PubMed ID: 14588125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and breast cancer: prospective results from the Women's Health Initiative.
    Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
    J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening in women: An integrative literature review.
    Ravert PK; Huffaker C
    J Am Acad Nurse Pract; 2010 Dec; 22(12):668-73. PubMed ID: 21129075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
    Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of breast imaging to screen women at high risk for cancer.
    Sickles EA
    Radiol Clin North Am; 2010 Sep; 48(5):859-78. PubMed ID: 20868890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.